Helius Medical Technologies

Neurotech company (Nasdaq: HSDT)

关于 Helius Medical Technologies

成立时间2014

Helius is a leading neurotechnology company in the medical device field, specializing in utilizing non-implantable platform technologies to treat neurological deficits, enhance the brain's compensatory abilities, and promote neuroplasticity, thereby improving the lives of patients with neurological disorders. The company has announced the establishment of the SOL Treasury.

社区
LinkedIn
Website
标签
Publicly listed company
Crypto Stocks

热度值变化趋势

团队成员

Dane C. Andreeff
Dane C. Andreeff

President and Chief Executive Officer

Jeffrey S. Mathiesen
Jeffrey S. Mathiesen

Chief Financial Officer

投资方

Pantera Capital
Pantera Capital
Summer Capital
Summer Capital

投融资详情

Post-IPO(2025-09-14)
金额¥36.00亿
投资方
Pantera Capital
Pantera Capital
Summer Capital
Summer Capital
估值--